<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-242 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-242</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-242</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <p><strong>Paper ID:</strong> paper-265231622</p>
                <p><strong>Paper Title:</strong> Investigating Common Mutations in Exon 20 and 21 of EGFR Gene in Lung Cancer Tumor Tissue of NSCLC Type</p>
                <p><strong>Paper Abstract:</strong> Background: A mutation in the EGFR gene can be a marker for non-small cell lung cancer (NSCLC). The frequency of this mutation is very different in various countries and ethnic groups. Objectives: This study investigated the frequency of mutations in exons 20 and 21 of the EGFR gene in patients with NSCLC in Iran. Methods: Twenty paraffin blocks with an average age of 3 years were prepared from the Tehran Cancer Institute. The samples belonged to 5 women and 15 men aged 61 - 74 years and were confirmed by a pathologist in terms of positivity and type of tumor. Afterdeparaffinization,DNAextractionwasperformedusingaQIAGENkit. Theappropriateprobesandprimersweredesigned,and finally, the samples were examined by the real-time TaqMan method, and the data were analyzed. Results: Thefindingsshowedthat15% and10% of patientshadmutationsinexon20and21of theEGFRgene,respectively. TheT790M mutation of exon 20 was observed in three patients (tumors of adenocarcinoma type and large cell cancer), and L858R and L861Q mutations of exon 21 of the EGFR gene were observed. Conclusions: The frequency of mutation in exon 20 and 21 of the EGFR gene in NSCLC patients among Iranians is close to Middle Eastern and European patients, but it is very different from the frequency of this mutation among East Asian and North Asian patients.</p>
                <p><strong>Cost:</strong> 0.012</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e242.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e242.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Iran-NSCLC-EGFR-Study-2023</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Investigating Common Mutations in Exon 20 and 21 of EGFR Gene in Lung Cancer Tumor Tissue of NSCLC Type</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Small cross-sectional TaqMan RT-PCR study of EGFR exon 20 and 21 mutations in 20 Iranian NSCLC tumor tissue blocks (Tehran Cancer Institute, 2020-2023); reports exon20 T790M and exon21 L858R/L861Q mutations and compares observed frequencies to regional and global literature.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>N = 20 NSCLC patients from Tehran Cancer Institute, Iran (Middle Eastern ethnicity inferred); 15 males and 5 females; ages 61-74; tumor histology: 6 squamous cell carcinoma, 5 adenocarcinoma, 9 large cell carcinoma. Samples collected 2020-2023 from FFPE tumor tissue blocks.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td>Exon 20: T790M (observed in 3 patients); Exon 21: L858R (observed in 1 patient), L861Q (observed in 1 patient).</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Mixed smoking status among cohort (table indicates both smokers and non-smokers). Authors report no statistically significant relationship between malignancy type and smoking (P > 0.05; Tukey's test P = 0.075). The paper notes a high rate of smoking in the large cell cancer subgroup but does not provide a precise smoking breakdown specific to mutation carriers.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Mutations observed across histologies: T790M seen in adenocarcinoma and large cell carcinoma; L861Q reported in a large cell carcinoma sample; L858R reported in a squamous cell carcinoma sample (per patient table).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Smoking and exposure to carcinogens are discussed as general contributors to lung cancer and mutation patterns; lifestyle and diet invoked as possible explanatory environmental factors for population-level differences.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Authors propose a closer gene pool/genetic similarity between Iranians and Middle Eastern/European populations (vs East Asians) as a contributor to similar EGFR mutation frequencies; family history present in 45% of cohort and 2/9 with family history had exon21 mutation (22.22% of those with family history).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No molecular biological mechanism provided; authors hypothesize that combined environmental and genetic factors (similar lifestyle/diet and genetic ancestry/gene pool) underlie why Iranian patients' EGFR mutation frequencies resemble Middle Eastern/European populations rather than East Asian populations.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Small sample size (N=20); sampling method bias (bronchoscopic biopsies more likely to sample central tumorsâ€”may under/over-represent certain histologies); limited regional comparative data in Middle East; potential lifestyle/screening differences between populations; lack of direct multi-ethnic comparison within the study.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>In this Iranian NSCLC sample, 15% of patients had EGFR exon 20 (T790M) mutations and 10% had exon 21 mutations (L858R and L861Q, each 5%); authors conclude Iranian EGFR mutation frequencies (exon 21) are similar to Middle Eastern and European patients but differ markedly from East Asian and North Asian populations, and they hypothesize lifestyle/diet and genetic ancestry as explanations.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e242.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e242.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR-prevalence-Asian-vs-nonAsian</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Reported EGFR mutation prevalence in NSCLC: Asian versus non-Asian populations (literature-cited statistic)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper cites prior molecular studies reporting markedly higher overall EGFR mutation prevalence in Asian NSCLC patients (~40%) compared with non-Asian patients (~20%).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Summary-level statement drawn from referenced molecular studies (not from the current cohort); populations described as 'Asian' vs 'non-Asian' in cited literature, no primary-sample details provided in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td>General EGFR activating mutations (not broken down by exon in this statement).</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td>40%</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td>20% (non-Asian)</td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Cited molecular studies indicate EGFR mutations are roughly twice as common in Asian NSCLC patients (~40%) compared with non-Asian patients (~20%), a motivating observation for why ethnicity-based prevalence comparisons are clinically important.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e242.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e242.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Iran_vs_EastAsia_Europe</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Comparative observation: Iranian EGFR mutation frequency versus East Asian and European populations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Authors' comparative interpretation that Iranian (Middle Eastern) patients have EGFR exon 21 mutation frequencies closer to European and Middle Eastern patients and different from East Asian and North Asian patients, despite geographic proximity to East Asia.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Based on the current Iranian cohort (N=20) and comparison with limited published regional/global data cited in the discussion.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td>Focused commentary on exon 21 mutation frequency (authors compare their exon21 findings to other populations).</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Authors note smoking patterns differ by histology and sex in general and discuss smoking as an environmental factor, but no direct stratified ethnic smoking comparison is performed.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Authors indicate histology distribution in their cohort (see primary study entry) and discuss how sampling method may influence observed histology frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Lifestyle and diet similarity invoked as environmental explanations for Iranian similarity to European/Middle Eastern EGFR frequencies rather than East Asian.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Authors suggest closer gene pool/genetic similarity between Iran and Middle Eastern/European populations vs East Asian populations as a potential factor.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>High-level hypothesis: population-level differences in EGFR mutation prevalence reflect combined effects of environmental exposures (lifestyle/diet) and underlying genetic ancestry/gene pool differences; no specific biological pathway mechanistic data presented.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Authors acknowledge possibility of limited prior regional data, sample-size limitations, and biopsy/sampling biases that could affect cross-population comparisons.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Despite geographic proximity to East Asia, Iranian NSCLC EGFR mutation frequencies (exon 21) appear more similar to Middle Eastern and European reports; authors propose environmental (lifestyle/diet) and genetic ancestry similarities as likely explanations but note limited data and small sample size.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis <em>(Rating: 2)</em></li>
                <li>Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS) <em>(Rating: 1)</em></li>
                <li>ctDNA assessment of EGFR mutation status in Chinese patients with advanced non-small cell lung cancer in real-world setting <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>